Takeda provides pipeline update and shares goal to increase revenue 50% by fy2030 at the 39th annual j.p. morgan healthcare conference

Osaka, japan & cambridge, mass.--(business wire)--takeda pharmaceutical company limited (tse:4502/nyse:tak) (“takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th annual j.p. morgan healthcare conference. president and chief executive officer, christophe weber, shared details on takeda's portfolio and pipeline strategy and financial outlook, including key programs expected to contribute to the company's revenue growth over the next dec
TAK Ratings Summary
TAK Quant Ranking